Clinical trial · Interventional
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
A Randomised Phase II/III Study to Compare the Combination of Carboplatin Plus Irinotecan Vs. the Combination of Carboplatin Plus Etoposide for SCLC in Extensive Disease Stage
NCT00168896CI-TRIAL-00000279unknownPhase 2 / Phase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Comparison of two combination chemotherapies in the treatment of patients with SLCL
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Small Cell Lung Cancer | Lung Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Carboplatin plus Irinotecan vs Carboplatin plus Etoposide | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Primary Endpoint:
- measure
- Documentation of the remission rate ( Phase II)
- measure
- Determination of progress free time (Phase III)
Secondary outcomes (5)
- measure
- Secondary Endpoint:
- measure
- Documentation of progress free time (Phase II)
- measure
- Documentation of objective remission rate ( Phase III)
- measure
- Documentation of 1-year survival rate
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * cytological or histological proven SCLC Stage I or II at 1st diagnosis * no prior chemotherapy * measurable tumor disease * karnofsky performance 70 Exclusion Criteria: * second malignancy ( except basal cell carcinoma, CA in situ Cervix uteri) * NYHA III * chronic diarrhea, obstructive bowel syndrome
References
Publications (0)
Data not yet available
No reference posted for this study.